Prodotti della ricerca

 

UNICA IRIS Institutional Research Information System

IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Cagliari dal mese di luglio 2015.

Mostra risultati da 41 a 60 di 156
successivo >  < precedente 
TitoloData di pubblicazioneAutore(i)RivistaEditore
Prevalenza del diabete mellito in pazienti sardi affetti da epatite cronica da virus C2006Solinas S; Cocco S; Asquas S; Cossu E; Chessa L
Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with peginterferon alfa-2a and ribavirin2006Cauli C; Serra G; Chessa L; Balestrieri A; Scioscia R; Lai ME; Farci PHAEMATOLOGICA
Epidemiologia delle epatiti virali in Italia e Sardegna2007Chessa L; Serra G; Balestrieri C
Association of chronic hepatitis C with major depressive disorders: irrespective of interferon-alpha therapy2007Carta MG; Hardoy MC; Garofalo A; Pisano E; Nonnoi V; Intilla G; Serra G; Balestrieri C; Chessa L;... Cauli C; Lai ME; Farci PCLINICAL PRACTICE AND EPIDEMIOLOGY IN MENTAL HEALTH
Treatment of chronic hepatitis D2007Farci P; Chessa L; Balestrieri C; Serra G; Lai MEJOURNAL OF VIRAL HEPATITIS
Long-latency potential study in minimal hepatic hencephalopaty2008Flore, M. A.; Chessa, L.; Puligheddu, M.; Genugu, F.; Balestrieri, A.; Fresu, F.; Lisai, M.; Gioi..., G.; Mammoliti, R.; Muroni, A.; Serra, G.; Balestrieri, C.; Iovine, M.; Corona, M.; Congiu, P.; Polizzi, L.; Marrosu, F.NEUROLOGICAL SCIENCES
Treatment of chronic hepatitis B: Recommendations from an Italian workshop2008Carosi, G.; Rizzetto, M.; Andreone, P.; Angelico, M.; Ascione, A.; Caporaso, N.; Fagiuolim, S.; F...attovich, G.; Mondelli, M.; Niro, G. A.; Pontisso, P.; Bonino, F.; Perno, C. F.; Prati, D.; Andreoni, M.; Angarano, G.; Annicchiarico, E.; Boncoraglio, R.; Brustia, D.; Calabrese, N.; Carlotto, A.; Cavalletto, L.; Cavina, M.; Chessa, L.; Croce, G.; De, Sanctis; Di, Candilo; F., Fabris; P., Fracassetti; O., Lanza; A. G., Giuberti; T., Guazzotti; G., Iacovazzi; T., Iovinella; V., Izzi; A., Loperfido; P., Magni; C. F., Marino; N., Messina; V., Michelone; •, Morante; R., Moretti; A., Nasta; P., Nauri; L., Paffetti; A., Pasino; M., Perboni; G., Petrelli; E., Picciotto; A., Pozzi; M., Purificato; F., Ay; •, Re; T., Az; •, Rinaldi; R., Sani; S., Santoro; R., Schioppa; O., Scotto; G., Siciliano; M., Sorbello; O., Squadrito; G., Taddei; M. T., Traversa; A., Tundo; . •Venezia G, .; Vilardo, L.; Zignego, A. L.; Zoncada, A.; Zuin, M.DIGESTIVE AND LIVER DISEASE
Co-infection par le virus del l’hepatite B et le virus de l’hepatite D2009Farci P; Chessa L; Lai ME
Efficacy, safety and impact on quality of life of a treatment with sorafenib in elderly cancer patients with advanced hepatocellular carcinoma. Preliminary results of a phase II study2009Mantovani, G; Massa, E; Spiga, C; Chessa, Luchino; Zolfino, T.
Efficacy, safety and impact on quality of life of a treatment with sorafenib in elderly cancer patients with advanced hepatocellular carcinoma. Preliminary results of a phase II study2009Mantovani G; Massa E; Spiga C; Chessa L; Zolfino T; Piras R; Madeddu C; Lepori S; Serra G; Marini SANNALS OF ONCOLOGY
EFFICACY, SAFETY AND IMPACT ON QUALITY OF LIFE OF A TREATMENT WITH SORAFENIB IN ELDERLY CANCER PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA. RESULTS OF A PHASE II STUDY2009Massa E; Spiga C; Chessa L; Zolfino T; Piras R; Madeddu C; Lepori S; Serra G; Marini S; Mantovani GANNALS OF ONCOLOGY
Efficacy, safety and impact on quality of life of Sorafenib in elderly patients with advanced Hepatocellular carcinoma. Preliminary results of a Phase II study2009Mantovani G; Massa E; Spiga C; Chessa L; Madeddu C; Zolfino T; Lepori S; Serra G; Piras MR; Marini SJOURNAL OF HEPATOLOGY
A multivariate approach for the brain impairment in patients with liver cirrhosi2009Basciu, F.; Congiu, P.; Corona, M.; Polizzi, L.; Gioi, G.; Fresu, F.; Chessa, L.; Puligheddu, M.;... Barberini, L.; Lisai, M.; Balestrieri, A.; Serra, C.; Balestrieri, C.; Marrosu, F.NEUROLOGICAL SCIENCES
Efficacy, safety and impact on quality of life of a treatment with sorafenib in ederly cancer patients with advanced hepatocellular carcinoma. Preliminary results of a phase II study2009Mantovani G; Massa E; Spiga C; Chessa L; Zolfino T; Piras R; Madeddu C; Lepori S; Serra G; Marini S
Risultati preliminari di uno studio di fase II con Sorafenib in pazienti anziani affetti da epatocarcinoma2009Massa E; Chessa L; Madeddu C; Zolfino T; Liguori S; Marini S; Dessì M; Mantovani GCANCER AND AGING
Prevalence of type-2 Diabetes in a populationof sardinian patients with chronic hepatitis C without cirrosis2011Chessa L; Cossu E; Serra G; Balestrieri C; Conti M; Iovine M; Casu S; Cappellini S; Casale M; Pas...etto MC; Onali S; Figorilli F; Lai ME; Farci P
Insulin resistance does not affect sustained virologic response in patients with chronic hepatitis C without cirrhosis treated with peg-interferon alfa 2a and ribavirin2011Chessa L; Serra G; Balestrieri C; Conti M; Casale M; Calabro C; Cappellini S; Casu S; Iovine M; C...ossu E; Lai ME; Farci PDIGESTIVE AND LIVER DISEASE
Sorafenib and locoregional treatment in patients with stage B and stage C HCC: Sardinian experience2011Zolfino, T; Piras, Mr; Zaru, S; Santona, Mc; Arcadu, F; Serra, G; Chessa, Luchino; Vidili, G; Spa...da, F; Enne, P; Bandiera, F.JOURNAL OF CLINICAL ONCOLOGY
Viral load reduction and virological response in HBeAg-negative chronic epatiti B treated with Peginterferon alfa 2a (PEG-IFN alfa 2a)2011Chessa L; Pasetto MC; Balestrieri C; Serra G; Conti M; Iovine M; Cappellini S; Casu S; Casale M; ...Figorilli F; Onali S; Lai ME; Farci P
Virological response and HBV DNA reduction during therapy with PegInterferon alfa-2a (Peg-IFN-2a) in patients affected by HBeAg negative chronic hepatitis B2012Chessa, Luchino; Serra, G; Balestrieri, C; Conti, M; Pasetto, Mc; Iovine, M; Cappellini, S; Casal...e M, Casu S.; Figorilli, F; Onali, S; Lai, Me; Farci, P.DIGESTIVE AND LIVER DISEASE
   
credits unica.it | accessibilità Università degli Studi di Cagliari
C.F.: 80019600925 - P.I.: 00443370929
note legali | privacy

Nascondi la toolbar